National Blood Authority Board

Established under the National Blood Authority Act 2003, the National Blood Authority (NBA) Board provides advice to the General Manager about the performance of the NBA's functions.  The Board is not a decision making body and has no formal or direct role in the governance or management of the NBA.  The Board does however, consider key strategic issues facing the NBA.

The NBA Board’s roles and responsibilities fall into three main categories:

  • Providing strategic direction;
  • Helping to ensure effective governance, including the provision of advice on fraud, audit and risk management and the monitoring of the NBA’s financial reporting; and
  • Liaising with stakeholders to strengthen relationships, promote the role of the NBA and contribute to the development of the organisation in a manner that furthers stakeholders’ requirements.

Membership

The Board is appointed by the Australian Government Minister for Health for a four-year term, based on nominees selected by the  Council of Australian Governments (COAG) Health Council (former Standing Council on Health (SCoH)). The Board is required to consist of:

  • A Chair;
  • A person representing the interests of the Commonwealth;
  • 1 or 2 persons representing the interests of the States and Territories;
  • A person representing the community
  • A person with expertise in public health issues relating to human blood; and
  • A person with financial or commercial expertise.

Further information is available from the NBA Board Secretariat by email (board [at] blood.gov.au) or by telephone (02 6151 5066).

Current Board Members

Ms Gayle Ginnane - Chair

Ms Gayle Ginnane was CEO of the Private Health Insurance Administration Council, a government agency reporting to the Minister for Health and Ageing, with financial and regulatory responsibility for the private health insurance industry until May 2008 and has broad experience as a senior manager in an insurance and regulatory environment, and an in depth understanding of governance, risk management and finance.

Ms Ginnane has considerable experience as an independent director on a number of boards, both commercial and not for profit, in the voluntary, government and private sectors. As well as Chair of the NBA Board, Ms Ginnane is a councillor on the Australian Pharmacy Council and a director of Police Health. She has also contributed to a number of voluntary organisations at senior and Board levels including Scouts ACT, the Arthur Shakespeare Foundation for Scouting and the Community Living Project.

Ms Ginnane is a member of the Institute of Public Administration, a fellow of the Australian Institute of Company Directors and an affiliate member of the Institute of Actuaries of Australia.

Ms Ginnane was re-appointed Chair of the NBA Board in January 2017.

Adjunct Professor Chris Brook – State/Territory representative (large jurisdiction)

Professor Chris Brook is an independent health policy consultant.

He has held the position of Chief Advisor Innovation, Safety and Quality for the Department of Health and Human Services (DHHS), Victoria, a flexible role that relates to in-depth analysis and thinking about major policy issues, separate from day-to-day operations. Examples include clinical trials, quality and safety, innovation and transformation approaches to improve services.

As a personal appointment, Professor Brook has also held the position of State Health and Medical Commander (Emergency Management). This position provides command and coordination across the whole of DHHS services, encompassing all hospitals, ambulances and others when a large scale emergency event occurs.

Professor Brook’s other appointments are:

• Chair of the Advisory Board of the Deakin School of Medicine

• Member of the Clinical Trials Advisory Committee (Commonwealth Department of Industry, Innovation and Science)

• Member of the Advisory Board of the Australian Commission on Safety and Quality in Health Care, and

• Member of Board of the Centre for Evidence in Intervention and Preventive Science.

Professor Brook was re-appointed to the NBA Board in January 2017. 

Professor Lyn Beazley AO - State/Territory representative (small jurisdiction)

After graduating from Oxford and Edinburgh Universities, Professor Lyn Beazley built an internationally renowned research team in neuroscience that focused on recovery from brain damage, with much of her investigations undertaken as Winthrop Professor at the University of Western Australia. Currently she is Sir Walter Murdoch Distinguished Professor of Science at Murdoch University.

Professor Beazley was the Chief Scientist of Western Australia from 2006 to 2013, advising the WA Government on science, innovation and technology, as well as acting as an Ambassador for science locally, nationally and internationally. Professor Beazley serves on several boards including the Federal Government’s Bionic Vision Australia and the WA State Government’s Technology and Industry Advisory Council. Professor Beazley was a Trustee of the Western Australian Museum from 1999 to 2006 and currently is Patron of the Friends of the Museum. Recently, Professor Beazley joined the Board of the Western Australian Art Gallery Foundation.

In 2009 Professor Beazley was awarded Officer of the Order of Australia and elected a Fellow of the Australian Academy of Technological Sciences and Engineering. In 2011 Professor Beazley was inducted into the inaugural Western Australian Women’s Hall of Fame and was elected a Fellow of the Australian College of Educators and a Companion of Engineers Australia. Professor Beazley has worked to promote Science, Technology, Engineering and Mathematics to the community, especially to young people, and in 2012 became the second recipient of the Governor’s Award for Giving, in recognition of her enthusiastic philanthropy. In 2015 she was inducted into the Western Australian Science Hall of Fame and was also announced the 2015 WA Australian of the Year.

Professor Beazley was appointed to the NBA Board in January 2017.

Mr Mark Cormack – Australian Government representative

Mr Mark Cormack is responsible for strategic national health policy, portfolio strategies and international engagement at the Department of Health. His national program responsibilities include primary health, mental health, public hospital funding agreements and dental.

Mr Cormack has worked in and for the public healthcare sector for over 30 years in various capacities as a health professional, senior manager, policy maker, planner, agency head and industry advocate. He has a Bachelor of Applied Science (University of Sydney) and Master of Health Management (University of Wollongong). Mr Cormack has had a number of senior roles in the public healthcare system, including Member of the Australian Health Ministers’ Advisory Council (AHMAC), Chair of the AHMAC Health Policy Priorities Principal Committee and Board Director of National E Health Transition Authority.

Prior to joining the Department of Health in February 2015 Mr Cormack was a Deputy Secretary in the Department of Immigration and Border Protection (DIBP) responsible for managing and resolving the immigration status of people who do not have legal authority to be in Australia or who are in breach of their visa conditions. His Group was also responsible for the onshore detention network, community detention, bridging visa program, and the Department’s compliance and removals functions. In addition he worked with other countries to implement offshore processing and refugee settlement. Mr Cormack was the Department’s senior executive responsible for implementation of Operation Sovereign Borders.

Mr Cormack was appointed the first Chief Executive Officer of Health Workforce Australia (HWA) in January 2010. HWA was a Commonwealth Statutory Authority, established by the Council of Australian Governments which planned, funded, researched and delivered programs to enhance and develop Australia’s health workforce.

From July 2006 to January 2010 Mr Cormack was Chief Executive of ACT Health.

Mr Cormack was re-appointed to the NBA Board in January 2017. 

Mr Paul Bedbrook – Financial expert

Mr Paul Bedbrook has had a connection with blood issues via his personal involvement with haemophilia for over two decades. He is the father of two adult sons with haemophilia. For much of this time Mr Bedbrook has been involved with the Haemophilia Foundation NSW (HFNSW) and the Haemophilia Foundation Australia (HFA). He is a past President of HFNSW and past Treasurer of HFA. He brings his personal experiences with blood issues to the Board as well as feedback from a community of individuals who rely on the blood and plasma products distributed to Australia's health services under the auspices of the NBA.

Professionally, Mr Bedbrook has had over 30 years of experience in financial services. His current roles include: Chairman of Zurich Financial Services Australia Ltd, Independent non-executive Director of Credit Union Australia (CUA) Ltd, Independent Chairman of ASX listed Elanor Investors Group, and Chairman of Disability Sports Australia.

Mr Bedbrook was a senior executive for over 20 years with the Dutch global banking, insurance and investment group, ING. Mr Bedbrook’s early career was as an Investment Analyst and Investment Portfolio Manager at ING, and between 1987 and 1995, he was the General Manager Investments and Chief Investment Officer for the Mercantile Mutual (ING) Group in Sydney. In the decade to 2010, Mr Bedbrook was President and CEO of INGDIRECT Canada, CEO and Director of ING Australia and Regional CEO of ING Asia Pacific based in Hong Kong.

Mr Bedbrook has been a member of the NBA Board since May 2011 and was appointed to his current Board role as financial expert in August 2013. Mr Bedbrook is also a member of the NBA Audit Committee. 

Associate Professor Alison Street AO - Public health expert

Professor Alison Street graduated in 1971 from Monash University with first class honours in medicine.

After completing postgraduate training in clinical and laboratory haematology in Melbourne and Sydney, Professor Street spent three years in clinical research in Boston. Professor Street returned to Melbourne to work with Monash University and Alfred Health in 1984, where she retired from the positions of Head of Laboratory Haematology and Haemostasis-Thrombosis (including Haemophilia) in 2012.

Professor Street’s main professional interests were in haemostasis-thrombosis, transfusion medicine and teaching. During her tenure at Alfred Health, Professor Street was Chief Examiner in haematology for the Royal College of Pathologists of Australasia between 2001 and 2006, and President of the Haematology Society of Australia and New Zealand between 1996 and 1998.

She was a Board member with the World Federation of Hemophilia (WFH) between 2002 and 2012 (Vice-President Medical between 2008 and 2012) and a Board member of the Australian Red Cross Blood Service (the Blood Service) between 1998 and 2004.

Professor Street’s current appointments are:

• Clinical Adjunct Associate Professor in the Department of Immunology and Pathology, Monash University

• Member of the Blood Service Advisory Committee

• Chair of the Blood Service Research Advisory Committee

• Chair of the NBA Haemovigilance Advisory Committee

• Consultant to the Department of Health for Clinical Haematology, and

• Member of the Steering Committee for the Asia-Pacific Haemophilia Working Group.

Professor Street received the Award of Officer in the Order of Australia in 2006 for services to haematology and the community of people with congenital bleeding disorders, and is an honorary life member of the Haematology Society of Australia and New Zealand, Australian Society of Thrombosis and Haemostasis and the Australian and New Zealand Society of Blood Transfusion.

Professor Street was appointed to the NBA Board in January 2017. 

Ms Patricia Warn – Community representative

Trained originally as a secondary school teacher in Tasmania, Ms Warn was a social and political researcher for the ABC's Four Corners program in Sydney for several years before becoming a Ministerial Advisor in Canberra across social security, health, community services and immigration. Ms Warn organised national community consultations to inform policy development in reforming disability services, women's health, HIV/AIDS, Creutzfeldt–Jakob disease awareness and aged care.

Ms Warn was a member of the Commonwealth Immigration Review Tribunal for five years. In retirement Ms Warn was appointed to the NSW Ministerial Advisory Committee on Ageing and became an official visitor to mental health facilities under the NSW Mental Health Act. She served for seven years as a Board member of Uniting Care Ageing's Sydney region and remains on its Advisory Council.

Ms Warn has been a lay member of the NSW Law Society's Professional Conduct Committee for a decade and has represented consumer interests on committees of the Australian Commission on Safety and Quality in Health Care, Health Workforce Australia, the Australian Council on Health Care Standards and the Australian Health Practitioner Registration Agency. She is on the Board of the Aged Rights Service (TARS) in Sydney.

Ms Warn's personal commitment to the NBA stems from her mother's life being saved by blood transfusions following a postpartum haemorrhage 60 years ago.

Ms Warn was appointed to the NBA Board as the community representative in August 2013.